BioPharma Credit PLC (LON:BPCR)

London flag London · Delayed Price · Currency is GBP · Price in USD
0.930
-0.010 (-1.06%)
At close: Mar 6, 2026
7.14%
Market Cap 798.06M
Revenue (ttm) 112.89M
Net Income (ttm) 89.87M
Shares Out 1.13B
EPS (ttm) 0.08
PE Ratio 8.97
Forward PE n/a
Dividend 0.07 (10.26%)
Ex-Dividend Date Feb 19, 2026
Volume 367,880
Average Volume 1,621,035
Open 0.942
Previous Close 0.940
Day's Range 0.930 - 0.940
52-Week Range 0.800 - 0.980
Beta 0.18
RSI 46.98
Earnings Date Mar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom. [Read more]

Sector Financials
Founded 2016
Country United Kingdom
Stock Exchange London Stock Exchange
Ticker Symbol BPCR
Full Company Profile

Financial Performance

In 2024, BioPharma Credit's revenue was $150.03 million, an increase of 10.53% compared to the previous year's $135.74 million. Earnings were $122.18 million, an increase of 12.66%.

Financial numbers in USD Financial Statements

News

There is no news available yet.